Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
Drugs Associated With Ischemic Stroke: A Review for Clinicians.

Stroke

Marto JP, Strambo D, Livio F, Michel P.
PMID: 34404236
Stroke. 2021 Oct;52(10):e646-e659. doi: 10.1161/STROKEAHA.120.033272. Epub 2021 Aug 18.

Certain drugs may increase the risk of ischemic stroke (IS). Our goal was to review associations between frequently used drugs and IS. We created an initial list of frequently used drugs to search Pubmed/MEDLINE from 1966 to 2020 and...

Cite
Marto JP, Strambo D, Livio F, et al. Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke. 2021;52(10):e646-e659doi: 10.1161/STROKEAHA.120.033272.
Marto, J. P., Strambo, D., Livio, F., & Michel, P. (2021). Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke, 52(10), e646-e659. https://doi.org/10.1161/STROKEAHA.120.033272
Marto, João Pedro, et al. "Drugs Associated With Ischemic Stroke: A Review for Clinicians." Stroke vol. 52,10 (2021): e646-e659. doi: https://doi.org/10.1161/STROKEAHA.120.033272
Marto JP, Strambo D, Livio F, Michel P. Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke. 2021 Oct;52(10):e646-e659. doi: 10.1161/STROKEAHA.120.033272. Epub 2021 Aug 18. PMID: 34404236.
Copy Download .nbib Format: NLM
Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer.

The Linacre quarterly

Williams WV, Mitchell LA, Carlson SK, Raviele KM.
PMID: 32431377
Linacre Q. 2018 Nov;85(4):412-452. doi: 10.1177/0024363918811637. Epub 2019 Jan 03.

Combined estrogen-progestogen contraceptives (oral contraceptives or OCs) and progestogen-only contraceptives (POCs) are synthetic steroids that bind to steroid hormone receptors, which are widespread throughout the body. They have a profound effect on cellular physiology. Combined OCs have been classified...

Cite
Williams WV, Mitchell LA, Carlson SK, et al. Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer. Linacre Q. 2019;85(4):412-452doi: 10.1177/0024363918811637.
Williams, W. V., Mitchell, L. A., Carlson, S. K., & Raviele, K. M. (2018). Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer. The Linacre quarterly, 85(4), 412-452. https://doi.org/10.1177/0024363918811637
Williams, William V, et al. "Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer." The Linacre quarterly vol. 85,4 (2018): 412-452. doi: https://doi.org/10.1177/0024363918811637
Williams WV, Mitchell LA, Carlson SK, Raviele KM. Association of Combined Estrogen-Progestogen and Progestogen-Only Contraceptives with the Development of Cancer. Linacre Q. 2018 Nov;85(4):412-452. doi: 10.1177/0024363918811637. Epub 2019 Jan 03. PMID: 32431377; PMCID: PMC6322132.
Copy Download .nbib Format: NLM
An Update on Contraception in Polycystic Ovary Syndrome.

Endocrinology and metabolism (Seoul, Korea)

Oguz SH, Yildiz BO.
PMID: 33853290
Endocrinol Metab (Seoul). 2021 Apr;36(2):296-311. doi: 10.3803/EnM.2021.958. Epub 2021 Apr 15.

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the first-line medical treatment for the long-term management of PCOS....

Cite
Oguz SH, Yildiz BO. An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab (Seoul). 2021;36(2):296-311doi: 10.3803/EnM.2021.958.
Oguz, S. H., & Yildiz, B. O. (2021). An Update on Contraception in Polycystic Ovary Syndrome. Endocrinology and metabolism (Seoul, Korea), 36(2), 296-311. https://doi.org/10.3803/EnM.2021.958
Oguz, Seda Hanife, and Yildiz, Bulent Okan. "An Update on Contraception in Polycystic Ovary Syndrome." Endocrinology and metabolism (Seoul, Korea) vol. 36,2 (2021): 296-311. doi: https://doi.org/10.3803/EnM.2021.958
Oguz SH, Yildiz BO. An Update on Contraception in Polycystic Ovary Syndrome. Endocrinol Metab (Seoul). 2021 Apr;36(2):296-311. doi: 10.3803/EnM.2021.958. Epub 2021 Apr 15. PMID: 33853290; PMCID: PMC8090477.
Copy Download .nbib Format: NLM
Drugs Associated With Ischemic Stroke: A Review for Clinicians.

Stroke

Marto JP, Strambo D, Livio F, Michel P.
PMID: 34404236
Stroke. 2021 Oct;52(10):e646-e659. doi: 10.1161/STROKEAHA.120.033272. Epub 2021 Aug 18.

Certain drugs may increase the risk of ischemic stroke (IS). Our goal was to review associations between frequently used drugs and IS. We created an initial list of frequently used drugs to search Pubmed/MEDLINE from 1966 to 2020 and...

Cite
Marto JP, Strambo D, Livio F, et al. Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke. 2021;52(10):e646-e659doi: 10.1161/STROKEAHA.120.033272.
Marto, J. P., Strambo, D., Livio, F., & Michel, P. (2021). Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke, 52(10), e646-e659. https://doi.org/10.1161/STROKEAHA.120.033272
Marto, João Pedro, et al. "Drugs Associated With Ischemic Stroke: A Review for Clinicians." Stroke vol. 52,10 (2021): e646-e659. doi: https://doi.org/10.1161/STROKEAHA.120.033272
Marto JP, Strambo D, Livio F, Michel P. Drugs Associated With Ischemic Stroke: A Review for Clinicians. Stroke. 2021 Oct;52(10):e646-e659. doi: 10.1161/STROKEAHA.120.033272. Epub 2021 Aug 18. PMID: 34404236.
Copy Download .nbib Format: NLM
The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.

Gynecologic oncology

Hemmingsen CH, Kjaer SK, Bennetsen AKK, Dehlendorff C, Baandrup L.
PMID: 34016454
Gynecol Oncol. 2021 Aug;162(2):469-474. doi: 10.1016/j.ygyno.2021.05.008. Epub 2021 May 18.

OBJECTIVE: To examine the association between reproductive factors and risk of non-epithelial ovarian cancer and to compare the associations with those in serous ovarian cancer.METHODS: From the Danish Cancer Registry, we identified all ovarian cancer cases (≥20 years old...

Cite
Hemmingsen CH, Kjaer SK, Bennetsen AKK, et al. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer. Gynecol Oncol. 2021;162(2):469-474doi: 10.1016/j.ygyno.2021.05.008.
Hemmingsen, C. H., Kjaer, S. K., Bennetsen, A. K. K., Dehlendorff, C., & Baandrup, L. (2021). The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer. Gynecologic oncology, 162(2), 469-474. https://doi.org/10.1016/j.ygyno.2021.05.008
Hemmingsen, Caroline H, et al. "The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer." Gynecologic oncology vol. 162,2 (2021): 469-474. doi: https://doi.org/10.1016/j.ygyno.2021.05.008
Hemmingsen CH, Kjaer SK, Bennetsen AKK, Dehlendorff C, Baandrup L. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer. Gynecol Oncol. 2021 Aug;162(2):469-474. doi: 10.1016/j.ygyno.2021.05.008. Epub 2021 May 18. PMID: 34016454.
Copy Download .nbib Format: NLM
Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy.

International journal of women's health

Xu L, Lee BS, Asif S, Kraemer P, Inki P.
PMID: 24920936
Int J Womens Health. 2014 May 27;6:547-54. doi: 10.2147/IJWH.S57470. eCollection 2014.

PURPOSE: To evaluate the patient satisfaction and health related quality of life (HRQoL) for levonorgestrel-releasing intrauterine system (LNG-IUS) versus conventional medical treatments ([CMTs] combined oral contraceptives, oral progestins, and antifibrinolytics, alone or in combination) in Asian women with heavy...

Cite
Xu L, Lee BS, Asif S, et al. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014;6:547-54doi: 10.2147/IJWH.S57470.
Xu, L., Lee, B. S., Asif, S., Kraemer, P., & Inki, P. (2014). Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. International journal of women's health, 6547-54. https://doi.org/10.2147/IJWH.S57470
Xu, Ling, et al. "Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy." International journal of women's health vol. 6 (2014): 547-54. doi: https://doi.org/10.2147/IJWH.S57470
Xu L, Lee BS, Asif S, Kraemer P, Inki P. Satisfaction and health-related quality of life in women with heavy menstrual bleeding; results from a non-interventional trial of the levonorgestrel-releasing intrauterine system or conventional medical therapy. Int J Womens Health. 2014 May 27;6:547-54. doi: 10.2147/IJWH.S57470. eCollection 2014. PMID: 24920936; PMCID: PMC4043813.
Copy Download .nbib Format: NLM
New and emerging contraceptives: a state-of-the-art review.

International journal of women's health

Bahamondes L, Bahamondes MV.
PMID: 24570597
Int J Womens Health. 2014 Feb 19;6:221-34. doi: 10.2147/IJWH.S46811. eCollection 2014.

BACKGROUND: The first hormonal contraceptive was introduced onto the market in several countries 50 years ago; however, the portfolio of contraceptive methods remains restricted with regards to their steroid composition, their cost, and their ability to satisfy the requirements...

Cite
Bahamondes L, Bahamondes MV. New and emerging contraceptives: a state-of-the-art review. Int J Womens Health. 2014;6:221-34doi: 10.2147/IJWH.S46811.
Bahamondes, L., & Bahamondes, M. V. (2014). New and emerging contraceptives: a state-of-the-art review. International journal of women's health, 6221-34. https://doi.org/10.2147/IJWH.S46811
Bahamondes, Luis, and Bahamondes, M Valeria. "New and emerging contraceptives: a state-of-the-art review." International journal of women's health vol. 6 (2014): 221-34. doi: https://doi.org/10.2147/IJWH.S46811
Bahamondes L, Bahamondes MV. New and emerging contraceptives: a state-of-the-art review. Int J Womens Health. 2014 Feb 19;6:221-34. doi: 10.2147/IJWH.S46811. eCollection 2014. PMID: 24570597; PMCID: PMC3933723.
Copy Download .nbib Format: NLM
The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases.

Intestinal research

Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW.
PMID: 30090040
Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27.

BACKGROUND/AIMS: To examine the association between use of oral contraceptive pills (OCPs) and the risk of developing inflammatory bowel diseases (IBD), in a modern cohort.METHODS: A prospective nested case-control study across sites in the Asia-Pacific region was conducted; involving...

Cite
Sanagapalli S, Ko Y, Kariyawasam V, et al. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018;16(3):409-415doi: 10.5217/ir.2018.16.3.409.
Sanagapalli, S., Ko, Y., Kariyawasam, V., Ng, S. C., Tang, W., de Silva, H. J., Chen, M., Wu, K., Aniwan, S., Ng, K. K., Ong, D., Ouyang, Q., Hilmi, I., Simadibrata, M., Pisespongsa, P., Gopikrishna, S., Leong, R. W. (2018). The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intestinal research, 16(3), 409-415. https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli, Santosh, et al. "The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases." Intestinal research vol. 16,3 (2018): 409-415. doi: https://doi.org/10.5217/ir.2018.16.3.409
Sanagapalli S, Ko Y, Kariyawasam V, Ng SC, Tang W, de Silva HJ, Chen M, Wu K, Aniwan S, Ng KK, Ong D, Ouyang Q, Hilmi I, Simadibrata M, Pisespongsa P, Gopikrishna S, Leong RW. The association between new generation oral contraceptive pill and the development of inflammatory bowel diseases. Intest Res. 2018 Jul;16(3):409-415. doi: 10.5217/ir.2018.16.3.409. Epub 2018 Jul 27. PMID: 30090040; PMCID: PMC6077300.
Copy Download .nbib Format: NLM
Showing 13 to 8 of 8 entries